Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merit Medical Systems, Inc. - Common Stock (NQ:MMSI)

85.27 -0.88 (-1.02%)
Streaming Delayed Price Updated: 1:58 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merit Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Merit Medical Systems (MMSI) Q1 Earnings: What To Expect
Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merit Medical Systems... 
Via StockStory
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and... 
Via StockStory
Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Looking Into Merit Medical Systems's Recent Short Interest
 
Via Benzinga
US-China Trade Tensions Poses Risk To Merit Medical's $150 Million Revenue From China
Merit Medical guides below consensus on FY25 EPS, projects up to $1.49 billion revenue, and faces tariff risks amid ongoing global manufacturing expansion. 
Via Benzinga
Topics World Trade
3 Reasons to Avoid MMSI and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit Medical Systems has surged 247% to $105.49 per share.... 
Via StockStory
Topics Stocks Supply Chain
How Do Investors Really Feel About Merit Medical Systems?
 
Via Benzinga
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
9 Analysts Have This To Say About Merit Medical Systems
 
Via Benzinga
What 8 Analyst Ratings Have To Say About Merit Medical Systems
 
Via Benzinga
Price Over Earnings Overview: Merit Medical Systems
 
Via Benzinga
Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
 
Via Benzinga
Assessing Merit Medical Systems: Insights From 12 Financial Analysts
 
Via Benzinga
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers. 
Via StockStory
3 Small-Cap Stocks Skating on Thin Ice
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
How Is The Market Feeling About Merit Medical Systems?
 
Via Benzinga
Where Merit Medical Systems Stands With Analysts
 
Via Benzinga
Key Takeaways From Merit Medical Systems Analyst Ratings
 
Via Benzinga
9 Analysts Assess Merit Medical Systems: What You Need To Know
 
Via Benzinga
Merit Medical Systems’s (NASDAQ:MMSI) Q4 Sales Top Estimates
Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s... 
Via StockStory
Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For
Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including... 
Via StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers. 
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems... 
Via StockStory
Merit Medical Systems To Purchase Cook Medical's Lead Management Portfolio In $200M Deal, Seeks To Enhance Its Position In Cardiac Intervention Market
Merit Medical Systems plans to acquire Cook Medical's lead management portfolio for $210 million, aiming to boost its electrophysiology and cardiac rhythm management business. The deal is expected to... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.